Article Text

Download PDFPDF
Letter
Increased incidence of GERD in GLP-1 treated patients: fact or artefact?

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • DRQ and JJM contributed equally.

  • Contributors DRQ and JJM contributed equally.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests DRQ has received a research award sponsored by Sanofi; has received honoraria for lectures, presentations, and educational events by Eli Lilly & Co. and Novo Nordisk; has received support for attending meetings and/or travel from Eli Lilly & Co. and Cook Medical. JJM has received lecture honoraria and consulting fees from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme (MSD), Novo Nordisk, Novartis and Sanofi; has received reimbursement of congress participation fees and travel expenses from MSD, Novo Nordisk, and Sanofi; and has initiated projects supported by Boehringer-Ingelheim, MSD, Novo Nordisk and Sanofi.

  • Provenance and peer review Not commissioned; externally peer reviewed.